Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children

被引:1
|
作者
Bardol, Maddlie [1 ]
Pan, Shan [1 ]
Walker, Suellen M. [2 ,3 ]
Standing, Joseph F. [1 ,4 ]
Dawes, Joy M. [1 ,2 ,5 ]
机构
[1] UCL, Great Ormond St Inst Child Hlth, Infect Immun & Inflammat, London, England
[2] Great Ormond St Hosp NHS Fdn Trust, Dept Anaesthesia & Pain Med, London, England
[3] UCL, UCL Great Ormond St Inst Child Hlth, Dev Neurosci Program, London, England
[4] Great Ormond St Hosp NHS Fdn Trust, Dept Pharm, London, England
[5] Great Ormond St Hosp Sick Children, Dept Anaesthesia, Great Ormond St London, London WC1N 3JH, England
基金
英国医学研究理事会;
关键词
children; pain; pharmacodynamic; pharmacokinetic; sedation; PEDIATRIC ANESTHESIA; BISPECTRAL INDEX; MIDAZOLAM; ENTROPY; PAIN; SIMULATION; CLEARANCE; TRIALS;
D O I
10.1111/pan.14712
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Pharmacokinetic pharmacodynamic modeling is an important tool which uses statistical methodology to provide a better understanding of the relationship between concentration and effect of drugs such as analgesics and sedatives. Pharmacokinetic pharmacodynamic models also describe between-subject variability that allows identification of subgroups and dose adjustment for optimal pain management in individual patients. This approach is particularly useful in the pediatric population, where most drugs have received limited evaluation and dosing is extrapolated from adult practice. In children, the covariates of weight and age are used to describe size- and maturation-related changes in pharmacokinetics. It is important to consider both size and maturation in order to develop an accurate model and determine the optimal dose for different age groups. An adequate assessment of analgesic and sedative effect using pain scales or brain activity measures is essential to build reliable pharmacokinetic pharmacodynamic models. This is often challenging in children due to the multidimensional nature of pain and the limited sensitivity and specificity of some measurement tools. This review provides a summary of the pharmacokinetic and pharmacodynamic methodology used to describe the dose-concentration-effect relationship of analgesics and sedation in children, with a focus on the different pharmacodynamic endpoints and the challenges of pharmacodynamic modeling.
引用
收藏
页码:781 / 792
页数:12
相关论文
共 50 条
  • [1] THE PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF ANALGESICS IN CHILDREN
    Jakobovic, Jasminka
    Butkovic, Diana
    PAEDIATRIA CROATICA, 2011, 55 (01) : 35 - 41
  • [2] Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children
    Anderson, Brian J.
    Hannam, Jacqueline A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (09) : 1393 - 1408
  • [3] Pharmacokinetic-pharmacodynamic relationships for analgesics
    Suri, A
    Estes, KS
    Geisslinger, G
    Derendorf, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (08) : 307 - 323
  • [4] Pharmacokinetic-Pharmacodynamic Modeling of Propofol in Children
    Rigouzzo, Agnes
    Servin, Frederique
    Constant, Isabelle
    ANESTHESIOLOGY, 2010, 113 (02) : 343 - 352
  • [5] SEDATIVES AND ANALGESICS
    TAYLOR, PM
    VETERINARY RECORD, 1986, 119 (09) : 213 - 213
  • [6] Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: Therapeutic implications
    Mazoit J.-X.
    Pediatric Drugs, 2006, 8 (3) : 139 - 150
  • [7] ANALGESICS, HYPNOTICS, AND SEDATIVES
    HOWELL, TH
    JOURNALS OF GERONTOLOGY, 1961, 16 (04): : 395 - 395
  • [8] SEDATIVES AND ANALGESICS IN LABOUR
    不详
    BRITISH MEDICAL JOURNAL, 1959, 2 (DEC12): : 1351 - 1351
  • [9] Pharmacokinetic and Pharmacodynamic Modeling in BioGears
    Clipp, Rachel B.
    Bray, Aaron
    Metoyer, Rodney
    Thames, M. Cameron
    Webb, Jeffrey B.
    2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2016, : 1467 - 1470
  • [10] PHARMACOKINETIC AND PHARMACODYNAMIC MODELING WITH PANCURONIUM
    EVANS, MA
    SHANKS, CA
    BROWN, KF
    TRIGGS, EJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) : 243 - 250